Amgen, Inc. (NASDAQ:AMGN)
CAPS Rating:
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
Invest Different
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
AMGN is a canary stock - cheep, cheep, cheep. Well-positioned as a trading stock given its volatility.
At upper end of its trading range and no longer screaming "cheep". It hasn't participated in the market rally over the past 3 months, but would likely participate in a market drop. Purely a trading decision on a long-term solid stock.